RATIONALE: Neurobiological models of addiction suggest that abnormalities of brain reward circuitry distort salience attribution and inhibitory control processes, which in turn contribute to high relapse rates. OBJECTIVES: The aim of this study is to determine whether impairments of salience attribution and inhibitory control predict relapse in a pharmacologically unaided attempt at smoking cessation. METHODS: One hundred forty one smokers were assessed on indices of nicotine consumption/dependence (e.g. The Fagerström Test of Nicotine Dependence, cigarettes per day, salivary cotinine) and three trait impulsivity measures. After overnight abstinence, they completed experimental tests of cue reactivity, attentional bias to smoking cues, response to financial reward, motor impulsiveness and response inhibition (antisaccades). They then started a quit attempt with follow-up after 7 days, 1 month and 3 months; abstinence was verified via salivary cotinine levels ≤20 ng/ml. RESULTS: Relapse rates at each point were 52.5%, 64% and 76.3%. The strongest predictor was pre-cessation salivary cotinine; other smoking/dependence indices did not explain additional outcome variance and neither did trait impulsivity. All experimental indices except responsivity to financial reward significantly predicted a 1-week outcome. Salivary cotinine, attentional bias to smoking cues and antisaccade errors explained unique as well as shared variance. At 1 and 3 months, salivary cotinine, motor impulsiveness and cue reactivity were all individually predictive; the effects of salivary cotinine and motor impulsiveness were additive. CONCLUSIONS: These data provide some support for the involvement of abnormal cognitive and motivational processes in sustaining smoking dependence and suggest that they might be a focus of interventions, especially in the early stages of cessation.
RATIONALE: Neurobiological models of addiction suggest that abnormalities of brain reward circuitry distort salience attribution and inhibitory control processes, which in turn contribute to high relapse rates. OBJECTIVES: The aim of this study is to determine whether impairments of salience attribution and inhibitory control predict relapse in a pharmacologically unaided attempt at smoking cessation. METHODS: One hundred forty one smokers were assessed on indices of nicotine consumption/dependence (e.g. The Fagerström Test of Nicotine Dependence, cigarettes per day, salivary cotinine) and three trait impulsivity measures. After overnight abstinence, they completed experimental tests of cue reactivity, attentional bias to smoking cues, response to financial reward, motor impulsiveness and response inhibition (antisaccades). They then started a quit attempt with follow-up after 7 days, 1 month and 3 months; abstinence was verified via salivary cotinine levels ≤20 ng/ml. RESULTS: Relapse rates at each point were 52.5%, 64% and 76.3%. The strongest predictor was pre-cessation salivary cotinine; other smoking/dependence indices did not explain additional outcome variance and neither did trait impulsivity. All experimental indices except responsivity to financial reward significantly predicted a 1-week outcome. Salivary cotinine, attentional bias to smoking cues and antisaccade errors explained unique as well as shared variance. At 1 and 3 months, salivary cotinine, motor impulsiveness and cue reactivity were all individually predictive; the effects of salivary cotinine and motor impulsiveness were additive. CONCLUSIONS: These data provide some support for the involvement of abnormal cognitive and motivational processes in sustaining smoking dependence and suggest that they might be a focus of interventions, especially in the early stages of cessation.
Authors: Lynne Dawkins; Jane H Powell; Robert West; John Powell; Alan Pickering Journal: Psychopharmacology (Berl) Date: 2006-10-18 Impact factor: 4.530
Authors: Jed E Rose; Frederique M Behm; Alfred N Salley; James E Bates; R Edward Coleman; Thomas C Hawk; Timothy G Turkington Journal: Neuropsychopharmacology Date: 2007-03-14 Impact factor: 7.853
Authors: Megan E Piper; Danielle E McCarthy; Daniel M Bolt; Stevens S Smith; Caryn Lerman; Neal Benowitz; Michael C Fiore; Timothy B Baker Journal: Nicotine Tob Res Date: 2008-06 Impact factor: 4.244
Authors: John R Hughes; Josue P Keely; Ray S Niaura; Deborah J Ossip-Klein; Robyn L Richmond; Gary E Swan Journal: Nicotine Tob Res Date: 2003-02 Impact factor: 4.244
Authors: Warren K Bickel; David P Jarmolowicz; E Terry Mueller; Kirstin M Gatchalian; Samuel M McClure Journal: Psychopharmacology (Berl) Date: 2012-03-24 Impact factor: 4.530
Authors: Saul Shiffman; Xiaoxue Li; Michael S Dunbar; Hilary A Tindle; Sarah M Scholl; Stuart G Ferguson Journal: Drug Alcohol Depend Date: 2015-07-29 Impact factor: 4.492
Authors: Elise Lesage; Sarah E Aronson; Matthew T Sutherland; Thomas J Ross; Betty Jo Salmeron; Elliot A Stein Journal: JAMA Psychiatry Date: 2017-06-01 Impact factor: 21.596
Authors: Adriaan Spruyt; Valentine Lemaigre; Bihiyga Salhi; Dinska Van Gucht; Helen Tibboel; Bram Van Bockstaele; Jan De Houwer; Jan Van Meerbeeck; Kristiaan Nackaerts Journal: Psychopharmacology (Berl) Date: 2015-03-13 Impact factor: 4.530